However, according to our results, genetic profiling for ABCB1 SNP rs4148738 and dTT measurement might be empirically indicated in AF patients with recurrent thromboembolic events, despite treatment with the 150 mg dabigatran regimen. This evidence concerns the gene ABCB1 and atrial fibrillation.